Literature DB >> 7566787

Adverse reactions associated with nefopam.

P I Pillans1, D J Woods.   

Abstract

AIM: To review postmarketing experience of adverse reactions associated with nefopam.
METHODS: Spontaneous reports of adverse reactions associated with nefopam over a 12 year period received by the New Zealand Centre for Adverse Reactions Monitoring were reviewed.
RESULTS: There were 70 reports of adverse reactions thought to be causally related to nefopam, most of which appear to be predictable extensions of the pharmacological effect of nefopam, and included confusion, hallucinations, convulsions, dizziness, headache, sweating, urinary retention, nausea, vomiting, tachycardia and palpitations. The first report of angina is described. Convulsions occurred in a stable epileptic in whom nefopam was contraindicated, and in another where the seizure threshold may have been lowered by a concomitant tricyclic antidepressant.
CONCLUSIONS: Nefopam can cause unpleasant adverse effects and there are important cautions and contraindications with this analgesic. A clearer presentation of its basic pharmacology in the datasheet should help to ensure appropriate use.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7566787

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  4 in total

1.  Status epilepticus caused by nefopam.

Authors:  Yong-Sook Park; Young-Baeg Kim; Jeong-Min Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-11-30

2.  Nefopam, a nonsedative benzoxazocine analgesic, selectively reduces the shivering threshold in unanesthetized subjects.

Authors:  Pascal Alfonsi; Frederic Adam; Andrea Passard; Bruno Guignard; Daniel I Sessler; Marcel Chauvin
Journal:  Anesthesiology       Date:  2004-01       Impact factor: 7.892

3.  A high throughput screen identifies Nefopam as targeting cell proliferation in β-catenin driven neoplastic and reactive fibroproliferative disorders.

Authors:  Raymond Poon; Helen Hong; Xin Wei; James Pan; Benjamin A Alman
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

4.  Nefopam for the prevention of perioperative shivering: a meta-analysis of randomized controlled trials.

Authors:  Meng Lv; Xuetao Wang; Wendong Qu; Mengjie Liu; Yuelan Wang
Journal:  BMC Anesthesiol       Date:  2015-06-09       Impact factor: 2.217

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.